These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36142945)

  • 1. Fighting Fatigue in Systemic Lupus Erythematosus: Experience of Dehydroepiandrosterone on Clinical Parameters and Patient-Reported Outcomes.
    Skoglund O; Walhelm T; Thyberg I; Eriksson P; Sjöwall C
    J Clin Med; 2022 Sep; 11(18):. PubMed ID: 36142945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing longitudinal patient-reported outcome measures between Swedish patients with recent-onset systemic lupus erythematosus and early rheumatoid arthritis.
    Heijke R; Björk M; Thyberg I; Kastbom A; McDonald L; Sjöwall C
    Clin Rheumatol; 2022 May; 41(5):1561-1568. PubMed ID: 34839415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of dehydroepiandrosterone on fatigue and well-being in women with quiescent systemic lupus erythematosus: a randomised controlled trial.
    Hartkamp A; Geenen R; Godaert GL; Bijl M; Bijlsma JW; Derksen RH
    Ann Rheum Dis; 2010 Jun; 69(6):1144-7. PubMed ID: 19854713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An open study of dehydroepiandrosterone in systemic lupus erythematosus.
    van Vollenhoven RF; Engleman EG; McGuire JL
    Arthritis Rheum; 1994 Sep; 37(9):1305-10. PubMed ID: 7945493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies of dehydroepiandrosterone (DHEA) as a therapeutic agent in systemic lupus erythematosus.
    Van Vollenhoven RF; McGuire JL
    Ann Med Interne (Paris); 1996; 147(4):290-6. PubMed ID: 8952750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of dehydroepiandrosterone on lumbar spine bone mineral density in patients with quiescent systemic lupus erythematosus.
    Hartkamp A; Geenen R; Godaert GL; Bijl M; Bijlsma JW; Derksen RH
    Arthritis Rheum; 2004 Nov; 50(11):3591-5. PubMed ID: 15529389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dehydroepiandrosterone treatment of women with mild-to-moderate systemic lupus erythematosus: a multicenter randomized, double-blind, placebo-controlled trial.
    Chang DM; Lan JL; Lin HY; Luo SF
    Arthritis Rheum; 2002 Nov; 46(11):2924-7. PubMed ID: 12428233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dehydroepiandrosterone for systemic lupus erythematosus.
    Crosbie D; Black C; McIntyre L; Royle PL; Thomas S
    Cochrane Database Syst Rev; 2007 Oct; 2007(4):CD005114. PubMed ID: 17943841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of dehydroepiandrosterone supplement on health-related quality of life in glucocorticoid treated female patients with systemic lupus erythematosus.
    Nordmark G; Bengtsson C; Larsson A; Karlsson FA; Sturfelt G; Rönnblom L
    Autoimmunity; 2005 Nov; 38(7):531-40. PubMed ID: 16373258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dehydroepiandrosterone (DHEA) and systemic lupus erythematosus.
    Derksen RH
    Semin Arthritis Rheum; 1998 Jun; 27(6):335-47. PubMed ID: 9662752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind, placebo-controlled, clinical trial of dehydroepiandrosterone in severe systemic lupus erythematosus.
    van Vollenhoven RF; Park JL; Genovese MC; West JP; McGuire JL
    Lupus; 1999; 8(3):181-7. PubMed ID: 10342710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dehydroepiandrosterone in systemic lupus erythematosus. Results of a double-blind, placebo-controlled, randomized clinical trial.
    van Vollenhoven RF; Engleman EG; McGuire JL
    Arthritis Rheum; 1995 Dec; 38(12):1826-31. PubMed ID: 8849355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormones and lupus: defective dehydroepiandrosterone activity induces impaired interleukin-2 activity of T lymphocytes in patients with systemic lupus erythematosus.
    Suzuki N; Suzuki T; Sakane T
    Ann Med Interne (Paris); 1996; 147(4):248-52. PubMed ID: 8952743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dehydroepiandrosterone in systemic lupus erythematosus: relationship between dosage, serum levels, and clinical response.
    Barry NN; McGuire JL; van Vollenhoven RF
    J Rheumatol; 1998 Dec; 25(12):2352-6. PubMed ID: 9858429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of systemic lupus erythematosus with dehydroepiandrosterone: 50 patients treated up to 12 months.
    van Vollenhoven RF; Morabito LM; Engleman EG; McGuire JL
    J Rheumatol; 1998 Feb; 25(2):285-9. PubMed ID: 9489820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-reported outcome measures in systemic lupus erythematosus by a web-based application: A randomized, crossover, agreement study.
    Uhrenholt L; Høstgaard S; Pedersen JF; Christensen R; Dreyer L; Leffers HCB; Taylor PC; Strand V; Jacobsen S; Voss A; Gregersen JW; Kristensen S
    Lupus; 2021 Nov; 30(13):2124-2134. PubMed ID: 34719299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Experience of Sirolimus Regarding Efficacy and Safety in Systemic Lupus Erythematosus.
    Eriksson P; Wallin P; Sjöwall C
    Front Pharmacol; 2019; 10():82. PubMed ID: 30787878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low serum levels of dehydroepiandrosterone may cause deficient IL-2 production by lymphocytes in patients with systemic lupus erythematosus (SLE).
    Suzuki T; Suzuki N; Engleman EG; Mizushima Y; Sakane T
    Clin Exp Immunol; 1995 Feb; 99(2):251-5. PubMed ID: 7851019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon Inhibition for Lupus with Anifrolumab: Critical Appraisal of the Evidence Leading to FDA Approval.
    Loncharich MF; Anderson CW
    ACR Open Rheumatol; 2022 Jun; 4(6):486-491. PubMed ID: 35157371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatigue in patients with systemic lupus erythematosus: the role of dehydroepiandrosterone sulphate.
    Overman CL; Hartkamp A; Bossema ER; Bijl M; Godaert GL; Bijlsma JW; Derksen RH; Geenen R
    Lupus; 2012 Dec; 21(14):1515-21. PubMed ID: 22936125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.